CRMD - CorMedix GAAP EPS of -$0.20 beats by $0.03 revenue of $0.06M beats by $0.05M March, 29 2022 04:06 PM CorMedix Inc. CorMedix press release (NASDAQ:CRMD): Q4 GAAP EPS of -$0.20 beats by $0.03. Revenue of $0.06M (flat Y/Y) beats by $0.05M. For further details see: CorMedix GAAP EPS of -$0.20 beats by $0.03, revenue of $0.06M beats by $0.05M